- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT07563556
Mind-Body Intervention in Earthquake Survivors: 6 mo RCT
Examining the Effect of Combined Mind-body Intervention in Earthquake Survivors: A 6 Months Follow-up Randomized Controlled Trial
The purpose of this study is to investigate whether a 4-week program called "Combined Mind-Body Intervention" can help survivors of the February 6, 2023, earthquakes manage stress and improve their ability to participate in daily activities. The study specifically aims to answer the following question: Does a program combining guided imagery and progressive muscle relaxation lead to significant, long-term improvements in occupational performance (self-care, work, and leisure), reduced stress levels, and better overall quality of life for earthquake survivors when compared to a control group?
The study will involve:
Target Population: Adults aged 18 to 65 who directly experienced the 2023 earthquakes and currently reside in the affected region .Intervention: Participants in the intervention group will attend eight individual sessions (twice a week) focusing on deep breathing, step-by-step muscle relaxation, and guided visualization of peaceful environments.
Evaluation: Changes in stress, mood, and daily activity performance will be measured at the beginning of the study, at the end of the 4-week program, and during a 6-month follow-up period to determine the lasting effects of the intervention.
Tutkimuksen yleiskatsaus
Tila
Ehdot
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Emine Sağlamoğlu, Master
- Puhelinnumero: +905388749386
- Sähköposti: eminesaglamoglu@gmail.com
Tutki yhteystietojen varmuuskopiointi
- Nimi: gamze ekici, professor
- Puhelinnumero: +903123052560
- Sähköposti: fztgamze@yahoo.com
Opiskelupaikat
-
-
-
Ankara, Turkki (Türkiye)
- Hacettepe University
-
Ottaa yhteyttä:
- Emine Sağlamoğlu
- Puhelinnumero: +905388749386
- Sähköposti: eminesaglamoglu@gmail.com
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Aikuinen
- Vanhempi Aikuinen
Hyväksyy terveitä vapaaehtoisia
Kuvaus
Inclusion Criteria:
- Being between 18 and 65 years old.
- Having directly experienced the February 6, 2023 earthquake.
- Currently residing in the earthquake zone.
- Possessing sufficient cognitive and language skills to participate in assessments and the intervention.
Exclusion Criteria:
- Having an additional psychiatric or neurological disease diagnosis.
- Having received non-pharmacological interventions (such as psychotherapy, CBT, art therapy, or meditation) before or during the study.
- Currently using psychiatric medications.
- Having a history of other physical (e.g., violence) or psychological trauma.
- Being pregnant or currently breastfeeding.
- Having a current substance addiction.
- Demonstrating suicidal tendencies.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Tukevaa hoitoa
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Combined Mind-Body Intervention
his group receives 8 individual sessions, conducted twice weekly for 30 to 40 minutes.Each session consists of Jacobson's progressive muscle relaxation and guided imagery techniques.Participants are also instructed to perform daily home practice
|
The intervention consists of 8 individual sessions (30-40 mins, twice weekly) combining Jacobson's Progressive Muscle Relaxation (PMR) and Guided Imagery.
Sessions begin with 5 minutes of diaphragmatic breathing.
PMR involves 15 minutes of tensing and relaxing specific muscle groups (limbs, face, trunk) to reduce physical tension.
This is followed by 15 minutes of Guided Imagery, visualizing sensory-rich "safe places" (e.g., childhood gardens) to promote emotional regulation.
Participants perform 15-minute daily home practice.
Sessions take place in a quiet, dimly lit environment with relaxing music.
For physiological standardization, participants avoid caffeine, nicotine, and food one hour before.
This occupational therapy protocol aims to enhance participation in daily activities (self-care, work, leisure) and reduce stress levels
|
|
Active Comparator: Control Group (Routine Care & Monitoring)
Participants receive routine care along with supplemental support.They will be contacted by phone twice a week for 4 weeks by the investigator to monitor their general health status.The phone calls are limited to general status inquiries to minimize bias related to investigator attention.
|
Participants receive their standard routine care.
Additionally, they will be contacted by phone twice a week for 4 weeks by the primary investigator to inquire about their general health and well-being.
These calls are limited to status inquiries to ensure that any observed changes in the study are due to the intervention itself rather than the attention provided by the researcher.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Canadian Occupational Performance Measure (COPM) - Performance and Satisfaction Scores
Aikaikkuna: Baseline, at the end of the 4-week intervention, and at the 6-month follow-up.
|
The COPM is a semi-structured interview used to identify and prioritize issues in occupational performance.
Participants rate their perceived performance and satisfaction for their top five identified problem areas in daily activities (self-care, productivity, and leisure).
Both scales use a 10-point Likert scale ranging from 1 ("not able to do it" or "not satisfied") to 10 ("able to do it extremely well" or "extremely satisfied") .
Higher scores indicate better occupational performance and higher satisfaction.
|
Baseline, at the end of the 4-week intervention, and at the 6-month follow-up.
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Hospital Anxiety and Depression Scale - Anxiety Sub-scale (HADS-A)
Aikaikkuna: Baseline, Week 4, and Month 6.
|
This 7-item sub-scale specifically measures anxiety levels.
Scores range from 0 to 21.
Higher scores indicate greater anxiety; lower scores reflect clinical improvement.
|
Baseline, Week 4, and Month 6.
|
|
Hospital Anxiety and Depression Scale - Depression Sub-scale (HADS-D)
Aikaikkuna: Baseline, Week 4, and Month 6.
|
This 7-item sub-scale specifically measures depression levels.
Scores range from 0 to 21.
Higher scores indicate more severe depression; lower scores reflect clinical improvement.
|
Baseline, Week 4, and Month 6.
|
|
Nottingham Health Profile (NHP) Domain Scores
Aikaikkuna: Baseline, Week 4, and Month 6.
|
Separate assessment of six domains: Physical Mobility (8 items), Pain (8 items), Sleep (5 items), Energy Level (3 items), Emotional Reactions (9 items), and Social Isolation (5 items).
Each domain is scored from 0 to 100.
Higher scores represent more severe problems in that specific area of health.
|
Baseline, Week 4, and Month 6.
|
Yhteistyökumppanit ja tutkijat
Sponsori
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Arvioitu)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muut tutkimustunnusnumerot
- 2026-231
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .